On November 28, 2024, the Commission published the results of an extensive ex-post study examining its past enforcement of merger control rules in the pharmaceutical sector (the “Study”).[1]
Latest Post
More Posts
New Commission Unveiled: What To Expect For Competition?
The Court of Justice Clarifies National Limitations Periods and Upholds Parties’ Right To Compensation In Follow-on Damages Actions
Subscribe: Subscribe via RSS
Blogs
Firm/Org